These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21309780)

  • 1. Time to rethink clinically important outcomes in platelet transfusion trials.
    Heddle NM; Arnold DM; Webert KE
    Transfusion; 2011 Feb; 51(2):430-4. PubMed ID: 21309780
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.
    Cook RJ; Heddle NM; Rebulla P; Sigouin CS; Webert KE;
    Transfusion; 2004 Aug; 44(8):1135-42. PubMed ID: 15265116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indication for platelet transfusion in patients with haematological diseases: less is more].
    Wandt H
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1877-9. PubMed ID: 20842610
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials evaluating pathogen-reduced platelet products: methodologic issues and recommendations.
    Cook RJ; Heddle NM
    Transfusion; 2013 Aug; 53(8):1843-55. PubMed ID: 23145927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of clinical wisdom in randomised studies, real-world registries and new hypotheses.
    Bernardi G; Morocutti G; Spedicato L; Zanuttini D
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):313-7. PubMed ID: 17443094
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical significance testing and clinical trials.
    Krause MS
    Psychotherapy (Chic); 2011 Sep; 48(3):217-22. PubMed ID: 21875234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation.
    Schiffer CA
    Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734
    [No Abstract]   [Full Text] [Related]  

  • 14. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 15. Design, operation, and interpretation of clinical trials.
    Pihlstrom BL; Barnett ML
    J Dent Res; 2010 Aug; 89(8):759-72. PubMed ID: 20581353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.
    D'Haens G; Sandborn WJ; Feagan BG; Geboes K; Hanauer SB; Irvine EJ; Lémann M; Marteau P; Rutgeerts P; Schölmerich J; Sutherland LR
    Gastroenterology; 2007 Feb; 132(2):763-86. PubMed ID: 17258735
    [No Abstract]   [Full Text] [Related]  

  • 17. Global benefit-risk assessment in designing clinical trials and some statistical considerations of the method.
    Pritchett YL; Tamura R
    Pharm Stat; 2008; 7(3):170-8. PubMed ID: 17538942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome measures in multiple sclerosis clinical trials.
    Andersson PB; Goodkin DE
    Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies.
    Heddle NM
    Transfus Med Rev; 1994 Jan; 8(1):15-28. PubMed ID: 8136604
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of platelet transfusion clinical trials.
    Corash L; Sherman CD
    Br J Haematol; 2011 May; 153(4):529-31; author reply 531-2. PubMed ID: 21275946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.